In the PROfound study, 81% of cfDNA samples yielded an NGS result, and with tumor tissue as a reference, the positive and negative percentage agreement for BRCA and ataxia-telangiectasia mutated (ATM) mutations was 81% and 92%, respectively [19]. This evidence concerns the gene ATM and neoplasm.